Bug barcode readers hold out promise of universal vaccines

Oct 15, 2009

Veterinary scientists have made a discovery that promises to deliver a new approach to fast development of cheap vaccines that are effective in all mammals - not just humans or another particular species. They propose that by harnessing the system that reads the biological 'barcodes' of infectious microbes such as food poisoning bacteria, flu viruses and protozoa that cause malaria, one vaccine could be made to prevent a particular disease in all mammals. The research is discussed in the new Autumn edition of Business, the quarterly magazine of the Biotechnology and Biological Sciences Research Council.

The scientists, led by Professor David Haig, University of Nottingham, Dr Tracey Coffey and Dr Jayne Hope, Institute for Animal Health, Compton, Professor Dirk Werling, Royal Veterinary College London and Dr Elizabeth Glass and Dr Oliver Jann, The Roslin Institute, have used a 'one medicine' approach, which recognises that many diseases and response are common across different species and removes the largely artificial distinction between humans and other animals. This approach can be particularly powerful when investigating zoonoses - diseases that jump the species barrier.

Researcher Professor Dirk Werling from the Royal Veterinary College, said: "Vaccines that are effective in several species are entirely feasible and could potentially be cost effective. Since any can be difficult and expensive to develop and manufacture, it would be desirable to really hone the effectiveness of a single vaccine so that it can be used in a variety of circumstances. What we have found is something that could be used to adapt one vaccine to many mammals.

"There are very subtle differences according to species, or even geographical location, in the system that alerts the immune system of a mammal to , viruses and other threats. This is down to tiny variations in how animals have evolved alongside these threats and manifests as slightly different forms of a type of molecule called a toll-like receptor or TLR. TLR's work like a barcode reader to identify a particular threat to the health of an animal and give the immune system the information it needs to respond and in this way are very important to determining the success of vaccination. Local differences in this system in humans might partly explain the variable success rate of Tuberculosis vaccination programmes around the world."

One way to make a good vaccine even more effective is to accompany it with a "helper substance", known as an adjuvant.

Professor Werling continued: "We already know that molecules that interact with TLRs make very good vaccine adjuvants and with the knowledge we have gained about species and geographical variations, we have the ability to use these strategically."

Professor Janet Allen, BBSRC Director of Research said: "When we embark on research to understand the fundamental workings of something as complicated as the immune system of mammals, we really don't know what gems we might discover. To be able to maintain the health of people and animals using one single vaccine would be a great development and shows that there is value in understanding the basic biology of how things work.

"There are infections by microbes such as Salmonella, E.coli and Campylobacter that can occur in many species and cause a significant risk to health and having a 'one medicine' approach to preventing and treating these can really only be a good thing."

More information: Click here to read the full article online.

Source: Biotechnology and Biological Sciences Research Council (news : web)

Explore further: Face transplants change lives, identity

add to favorites email to friend print save as pdf

Related Stories

Groundbreaking, lifesaving TB vaccine a step closer

Oct 08, 2008

Researchers at Aberystwyth University, following a number of years of investment by the Biotechnology and Biological Sciences Research Council (BBSRC), have licensed ground-breaking research to a non-profit product development ...

Scientists discover how common vaccine booster works

May 21, 2008

In an online paper in the journal Nature, Yale University researchers funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, explain how a common ingredient in man ...

Bird flu vaccine protects people and pets

Oct 20, 2008

A single vaccine could be used to protect chickens, cats and humans against deadly flu pandemics, according to an article published in the November issue of the Journal of General Virology. The vaccine protects birds and ma ...

Recommended for you

Face transplants change lives, identity

8 hours ago

Patients are prepared to take significant risks in order to be considered for a face transplant, says Dr David Koppel, director of the largest craniofacial unit in the UK and Honorary Clinical Associate Professor ...

British Lords hold ten-hour debate on assisted dying

Jul 19, 2014

Members of Britain's unelected House of Lords spent almost ten hours on Friday discussing whether to legalise assisted dying, in an often emotional debate putting the question back on the agenda, if not on the statute books.

AbbVie, Shire agree on $55B combination

Jul 18, 2014

The drugmaker AbbVie has reached a deal worth roughly $55 billion to combine with British counterpart Shire and become the latest U.S. company to seek an overseas haven from tax rates back home.

User comments : 0